All News
Filter News
Found 101 articles
-
Government of Canada signs new agreements to secure additional vaccine candidate and treatment for COVID-19
9/22/2020
The Government of Canada is protecting the health and safety of all Canadians, while ensuring a safe and sustainable economic recovery.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 18, 2020.
-
He also said they would be able to deliver 100 million doses to the U.S. government in the “first few months of 2021.”
-
Although it is increasingly likely that one of the COVID-19 vaccines currently being tested will be approved or receive Emergency Use Authorization before the end of the year, experts are increasingly warning that widespread distribution may take a much longer time.
-
The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Moderna, Novavax, Pfizer, Merck and Sanofi all signed the pledge promising to ensure that any vaccine put forth by one or more of the companies meets the rigorous standards for approval.
-
When Moncef Slaoui was tapped to helm Operation Warp Speed, he sought confirmation that politics would not play a role in driving certain treatments through an approval process without the proper supporting scientific data to back it up.
-
“Today’s announcement puts another building block in place as the Nation moves toward a safe and effective COVID-19 vaccine,” stated Robert Redfield, director of the U.S. Centers for Disease Control and Prevention.
-
Clinical Transparency Proponents Question Safety and Efficacy of Russia’s COVID-19 Vaccine
8/13/2020
While Russian President Vladimir Putin expressed confidence in the preventative medication against the novel coronavirus, scientists from across the globe expressed concern over the lack of available data. -
AstraZeneca’s COVID-19 vaccine candidate induced significant immune responses in the majority of patients following a single dose in a Phase I study. The preventative medication also proved to be fairly safe, study results showed.
-
Recent Discovery in the Cure for Herpes is Overshadowed by the Covid -19 Quest for a VaccineLack of coverage has left millions infected with herpes in the dark.
7/7/2020
The race is on to find a vaccine for COVID-19, the illness caused by the novel coronavirus.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 12, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 3, 2020.
-
Industry experts say a vaccine against the SARS-CoV-2 virus will either be ready this fall, at the end of the year or 18 months from now, depending on the vaccine and how they define “ready.”
-
Doctors on the Front Lines Are Testing New Therapies to Treat COVID-19
6/3/2020
Researchers have been working furiously to identify medications to combat the novel coronavirus that causes COVID-19.
-
The Maryland-based company has enrolled and dosed its first patients in a Phase I/II study.
-
The hopes of billions of people are riding on at least one of the vaccine candidates for COVID-19 currently in clinical development becoming a commercialized preventative treatment for the world. While hopes are high, caution is still being urged by drugmakers and epidemiologists.
-
Clinical Catch-Up: May 11-15
5/18/2020
Clinical trial updates not related to COVID-19 are on the upswing, partly because some companies are announcing trial information ahead of the upcoming American Society of Clinical Oncology virtual meeting being held at the end of the month. Here’s a look. -
In an interview with National Geographic, Fauci once again sided with the evidence that indicates the virus is a species jumper and originated in the animal kingdom.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 1, 2020.
-
Pfizer and Germany-based BioNTech are collaborating on a messenger RNA vaccine against SARS-CoV-2, the novel coronavirus that causes COVID-19.